Andrés Parra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Andrés Parra has a total of 172 co-authors. Here are the top co-authors by number of shared publications:
- Francisco Rivas
Department of Organic Chemistry, Faculty of Sciences, University of Granada, Av. Fuentenueva 1, 18071 Granada, Spain
33 shared publications - Antonio Martínez
Departamento de Quimica Organica, Facultad de Ciencias, Universidad de Granada, E-18071 Granada, Spain
23 shared publications Andrés García-Granados
Department of Organic Chemistry, Faculty of Science, University of Granada, 18071 Granada, Spain
18 shared publications- Marta Medina-O’donnell
Department of Organic Chemistry, Faculty of Sciences, University of Granada, Av. Fuentenueva 1, 18071 Granada, Spain
15 shared publications Andres Garcia-Granados
Departamento de Química Orgánica, Facultad de Ciencias, Universidad de Granada, Granada, Spain
13 shared publications- Fernando Jesús Reyes Zurita
Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, 18071 Granada, Spain
12 shared publications
Latest Publications
- Open Access
- 21 December 2022
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 86 (1) , 166-175
Synthesis, Optical Properties, and Antiproliferative Evaluation of NBD-Triterpene Fluorescent Probes
- 21 December 2022
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 86 (1) , 166-175
Open AccessSynthesis, Optical Properties, and Antiproliferative Evaluation of NBD-Triterpene Fluorescent Probes
- Open Access
- 29 July 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (15) , 8158
Efficient In Vitro and In Vivo Anti-Inflammatory Activity of a Diamine-PEGylated Oleanolic Acid Derivative
Recent evidence has shown that inflammation can contribute to all tumorigenic states. We have investigated the anti-inflammatory effects of a diamine-PEGylated derivative of oleanolic acid (OADP), in vitro and in vivo with inflammation models. In addition, we have determined the sub-cytotoxic concentrations for anti-inflammatory assays of OADP in RAW 264.7 cells. The inflammatory process began with incubation with lipopolysaccharide (LPS). Nitric oxide production levels were also determined, exceeding 75% inhibition of NO for a concentration of 1 µg/mL of OADP. Cell-cycle analysis showed a reversal of the arrest in the G0/G1 phase in LPS-stimulated RAW 264.7 cells. Furthermore, through Western blot analysis, we have determined the probable molecular mechanism activated by OADP; the inhibition of the expression of cytokines such as TNF-α, IL-1β, iNOS, and COX-2; and the blocking of p-IκBα production in LPS-stimulated RAW 264.7 cells. Finally, we have analyzed the anti-inflammatory action of OADP in a mouse acute ear edema, in male BL/6J mice treated with OADP and tetradecanoyl phorbol acetate (TPA). Treatment with OADP induced greater suppression of edema and decreased the ear thickness 14% more than diclofenac. The development of new derivatives such as OADP with powerful anti-inflammatory effects could represent an effective therapeutic strategy against inflammation and tumorigenic processes.
- 29 July 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (15) , 8158
Open AccessEfficient In Vitro and In Vivo Anti-Inflammatory Activity of a Diamine-PEGylated Oleanolic Acid Derivative
Recent evidence has shown that inflammation can contribute to all tumorigenic states. We have investigated the anti-inflammatory effects of a diamine-PEGylated derivative of oleanolic acid (OADP), in vitro and in vivo with inflammation models. In addition, we have determined the sub-cytotoxic concentrations for anti-inflammatory assays of OADP in RAW 264.7 cells. The inflammatory process began with incubation with lipopolysaccharide (LPS). Nitric oxide production levels were also determined, exceeding 75% inhibition of NO for a concentration of 1 µg/mL of OADP. Cell-cycle analysis showed a reversal of the arrest in the G0/G1 phase in LPS-stimulated RAW 264.7 cells. Furthermore, through Western blot analysis, we have determined the probable molecular mechanism activated by OADP; the inhibition of the expression of cytokines such as TNF-α, IL-1β, iNOS, and COX-2; and the blocking of p-IκBα production in LPS-stimulated RAW 264.7 cells. Finally, we have analyzed the anti-inflammatory action of OADP in a mouse acute ear edema, in male BL/6J mice treated with OADP and tetradecanoyl phorbol acetate (TPA). Treatment with OADP induced greater suppression of edema and decreased the ear thickness 14% more than diclofenac. The development of new derivatives such as OADP with powerful anti-inflammatory effects could represent an effective therapeutic strategy against inflammation and tumorigenic processes.
- Open Access
- 6 May 2021
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 84 (5) , 1587-1597
Synthesis and Biological Activity of Triterpene–Coumarin Conjugates
A set of 12 maslinic acid–coumarin conjugates was synthesized, with 9 being maslinic acid–diamine–coumarin conjugates at the C-28 carboxylic acid group of triterpene acid and the other three being maslinic acid–coumarin conjugates at C-2/C-3 and/or C-28 of the triterpene skeleton. The cytotoxic effects of these 12 triterpene conjugates were evaluated in three cancer cell lines (B16-F10, HT29, and Hep G2) and compared, respectively, with three nontumor cell lines from the same or similar tissue (HPF, IEC-18, and WRL68). The most potent cytotoxic results were achieved by a conjugate with two molecules of coumarin-3-carboxylic acid coupled through the C-2 and C-3 hydroxy groups of maslinic acid. This conjugate showed submicromolar IC50 values in two of the three cancer cell lines tested (0.6, 1.1, and 0.9 μM), being between 110- and 30-fold more effective than its corresponding precursor. Furthermore, this conjugate (10) showed percentages of cell viability for the three nontumor lines of 90%. Four maslinic acid–coumarin conjugates displayed apoptotic effects in the treated cells, with total apoptosis rates of between 40 and 85%, relative to the control. Almost all the compounds assayed caused cell-cycle arrest in all cancer cell lines, increasing the number of these cells in the G0/G1 phase.
- 6 May 2021
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 84 (5) , 1587-1597
Open AccessSynthesis and Biological Activity of Triterpene–Coumarin Conjugates
A set of 12 maslinic acid–coumarin conjugates was synthesized, with 9 being maslinic acid–diamine–coumarin conjugates at the C-28 carboxylic acid group of triterpene acid and the other three being maslinic acid–coumarin conjugates at C-2/C-3 and/or C-28 of the triterpene skeleton. The cytotoxic effects of these 12 triterpene conjugates were evaluated in three cancer cell lines (B16-F10, HT29, and Hep G2) and compared, respectively, with three nontumor cell lines from the same or similar tissue (HPF, IEC-18, and WRL68). The most potent cytotoxic results were achieved by a conjugate with two molecules of coumarin-3-carboxylic acid coupled through the C-2 and C-3 hydroxy groups of maslinic acid. This conjugate showed submicromolar IC50 values in two of the three cancer cell lines tested (0.6, 1.1, and 0.9 μM), being between 110- and 30-fold more effective than its corresponding precursor. Furthermore, this conjugate (10) showed percentages of cell viability for the three nontumor lines of 90%. Four maslinic acid–coumarin conjugates displayed apoptotic effects in the treated cells, with total apoptosis rates of between 40 and 85%, relative to the control. Almost all the compounds assayed caused cell-cycle arrest in all cancer cell lines, increasing the number of these cells in the G0/G1 phase.
- Open Access
- 12 November 2020
- Published by MDPI AG in Materials Proceedings
- Vol. 4 (1) , 6
Maslinic Acid Nanoparticles: A Drug to Carry Others
Maslinic acid (MA), a triterpene widely found in natural sources, is a compound which is gaining interest due to its multiple therapeutic activities and its lack of harmful effects. However, MA is practically insoluble in water, which limits its clinical application. Here, we present a solvent displacement method to produce MA Solid Lipid Nanoparticles (SLNs) as a nanoplatform to carry hydrophobic drugs. A systematic study of the experimental parameters that may have some influence on the colloidal characteristics of MA SLNs was carried out. The effect of the aqueous/organic phase volume ratio and the organic phase composition on the size of SLNs evidence the role of the solvent diffusivity on the colloidal characteristic of the SLNs. On the other hand, the effect of surfactant/MA ratio proved the relevance of the surfactant on stabilizing the SLNs interface, owing to the changes on the interfacial tension that it promotes. MA SLNs have proved to be highly stable over time and in a wide range of pH and salinity conditions, as well as having a high curcumin encapsulation efficiency. The MA SLNs prepared in this work provide a starting point to develop functionalized active nanocarriers which allow establishing a synergistic relation with the loaded drug.
- 12 November 2020
- Published by MDPI AG in Materials Proceedings
- Vol. 4 (1) , 6
Open AccessMaslinic Acid Nanoparticles: A Drug to Carry Others
Maslinic acid (MA), a triterpene widely found in natural sources, is a compound which is gaining interest due to its multiple therapeutic activities and its lack of harmful effects. However, MA is practically insoluble in water, which limits its clinical application. Here, we present a solvent displacement method to produce MA Solid Lipid Nanoparticles (SLNs) as a nanoplatform to carry hydrophobic drugs. A systematic study of the experimental parameters that may have some influence on the colloidal characteristics of MA SLNs was carried out. The effect of the aqueous/organic phase volume ratio and the organic phase composition on the size of SLNs evidence the role of the solvent diffusivity on the colloidal characteristic of the SLNs. On the other hand, the effect of surfactant/MA ratio proved the relevance of the surfactant on stabilizing the SLNs interface, owing to the changes on the interfacial tension that it promotes. MA SLNs have proved to be highly stable over time and in a wide range of pH and salinity conditions, as well as having a high curcumin encapsulation efficiency. The MA SLNs prepared in this work provide a starting point to develop functionalized active nanocarriers which allow establishing a synergistic relation with the loaded drug.
- Open Access
- 28 September 2020
- Published by MDPI AG in Biomolecules
- Vol. 10 (10) , 1375
A Diamine-PEGylated Oleanolic Acid Derivative Induced Efficient Apoptosis through a Death Receptor and Mitochondrial Apoptotic Pathway in HepG2 Human Hepatoma Cells
Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Our recent studies have shown that the diamine-(PEG)ylated oleanolic acid (OADP) has strong anti-tumor effects in HCCs. In this study, we evaluated the anti-tumor mechanisms of OADP in the HepG2 HCC cell line. The cytotoxicity results showed that HepG2 cell viability was markedly reduced, with a very low 50% of cell growth inhibitory concentration (IC50, 0.14 µg/mL). We then investigated the anti-tumor mechanisms of OADP in HepG2 cells. The flow-cytometry analysis was used to evaluate cell apoptosis, indicating that 74–95% of cells were apoptotic. OADP caused cell cycle arrest in the G0/G1 phase and the loss of the mitochondrial membrane potential (MMP). Western blot analysis was performed to assess the expression levels of key proteins associated with the underlying molecular mechanism. The results showed the clear upregulation of caspase-8, caspase-9, caspase-3, Bak, p21, and p53, accompanied by the downregulation of Bcl-2. Similar results were obtained by the cotreatment with OADP and the c-Jun N-terminal kinase (JNK) inhibitor SP600125. Agents such as OADP, which are capable of activating extrinsic and intrinsic apoptotic pathways, may represent potential HCC cancer therapies.
- 28 September 2020
- Published by MDPI AG in Biomolecules
- Vol. 10 (10) , 1375
Open AccessA Diamine-PEGylated Oleanolic Acid Derivative Induced Efficient Apoptosis through a Death Receptor and Mitochondrial Apoptotic Pathway in HepG2 Human Hepatoma Cells
Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Our recent studies have shown that the diamine-(PEG)ylated oleanolic acid (OADP) has strong anti-tumor effects in HCCs. In this study, we evaluated the anti-tumor mechanisms of OADP in the HepG2 HCC cell line. The cytotoxicity results showed that HepG2 cell viability was markedly reduced, with a very low 50% of cell growth inhibitory concentration (IC50, 0.14 µg/mL). We then investigated the anti-tumor mechanisms of OADP in HepG2 cells. The flow-cytometry analysis was used to evaluate cell apoptosis, indicating that 74–95% of cells were apoptotic. OADP caused cell cycle arrest in the G0/G1 phase and the loss of the mitochondrial membrane potential (MMP). Western blot analysis was performed to assess the expression levels of key proteins associated with the underlying molecular mechanism. The results showed the clear upregulation of caspase-8, caspase-9, caspase-3, Bak, p21, and p53, accompanied by the downregulation of Bcl-2. Similar results were obtained by the cotreatment with OADP and the c-Jun N-terminal kinase (JNK) inhibitor SP600125. Agents such as OADP, which are capable of activating extrinsic and intrinsic apoptotic pathways, may represent potential HCC cancer therapies.
- 16 October 2019
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 82 (10) , 2886-2896
Oleanolic Acid Derivatives as Potential Inhibitors of HIV-1 Protease
Pentacyclic triterpenes, such as oleanolic acid (I), are promising scaffolds for diversification through the use of combinatorial methods to obtain derivatives that improve their biological properties, increasing their bioavailability and enhancing their therapeutic efficacy. The purpose of this study was to evaluate the influence that derivatives of oleanolic acid, conjugated with one or two amino acids and an acyl group, might exert on HIV-1 protease inhibition. The in vitro studies conducted suggested that the presence of a carboxyacyl group generally improves the inhibition of HIV-1 protease, especially when a phthaloyl group is present, with IC50 concentration values below 5 μM. The gain in activity of three 3-phthaloyl derivatives, with sub-micromolar IC50 values, was between 60- and 100-fold more active than oleanolic acid. A molecular docking study has also been performed to elucidate the mode of binding to the protease by these oleanolic acid derivatives. In general, the derivatives that exhibited the highest inhibitory activity of HIV-1 protease also showed the highest binding energies in docking simulations. The overall results suggest that the coupling of one or two amino acids and a phthaloyl group to oleanolic acid improves HIV-1 protease inhibition, implying that these triterpene derivatives may be promising antiviral agents against HIV.
- 16 October 2019
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 82 (10) , 2886-2896
Oleanolic Acid Derivatives as Potential Inhibitors of HIV-1 Protease
Pentacyclic triterpenes, such as oleanolic acid (I), are promising scaffolds for diversification through the use of combinatorial methods to obtain derivatives that improve their biological properties, increasing their bioavailability and enhancing their therapeutic efficacy. The purpose of this study was to evaluate the influence that derivatives of oleanolic acid, conjugated with one or two amino acids and an acyl group, might exert on HIV-1 protease inhibition. The in vitro studies conducted suggested that the presence of a carboxyacyl group generally improves the inhibition of HIV-1 protease, especially when a phthaloyl group is present, with IC50 concentration values below 5 μM. The gain in activity of three 3-phthaloyl derivatives, with sub-micromolar IC50 values, was between 60- and 100-fold more active than oleanolic acid. A molecular docking study has also been performed to elucidate the mode of binding to the protease by these oleanolic acid derivatives. In general, the derivatives that exhibited the highest inhibitory activity of HIV-1 protease also showed the highest binding energies in docking simulations. The overall results suggest that the coupling of one or two amino acids and a phthaloyl group to oleanolic acid improves HIV-1 protease inhibition, implying that these triterpene derivatives may be promising antiviral agents against HIV.
- 3 July 2019
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 5 (9) , 1581-1589
Novel Oleanolic and Maslinic Acid Derivatives as a Promising Treatment against Bacterial Biofilm in Nosocomial Infections: An in Vitro and in Vivo Study
Oleanolic Acid (OA) and Maslinic Acid (MA) are pentacyclic triterpenic compounds that abound in the industrial olive-oil waste. These compounds have renowned antimicrobial properties and lack cytotoxicity in eukaryotic cells as well as resistance mechanisms in bacteria. Despite these advantages, their antimicrobial activity has only been tested in vitro, and derivatives improving this activity have not been reported. In this work, a set of 14 OA and MA C-28 amide derivatives have been synthesized. Two of these derivatives, MA-HDA and OA-HDA, increase the in vitro antimicrobial activity of the parent compounds while reducing their toxicity in most of the Gram-positive bacteria tested, including a methicillin-resistant Staphylococcus aureus-MRSA. MA-HDA also shows an enhanced in vivo efficacy in a Galleria mellonella invertebrate animal model of infection. A preliminary attempt to elucidate their mechanism of action revealed that these compounds are able to penetrate and damage the bacterial cell membrane. More significantly, their capacity to reduce antibiofilm formation in catheters has also been demonstrated in two sets of conditions: a static and a more challenged continuous-flow S. aureus biofilm.
- 3 July 2019
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 5 (9) , 1581-1589
Novel Oleanolic and Maslinic Acid Derivatives as a Promising Treatment against Bacterial Biofilm in Nosocomial Infections: An in Vitro and in Vivo Study
Oleanolic Acid (OA) and Maslinic Acid (MA) are pentacyclic triterpenic compounds that abound in the industrial olive-oil waste. These compounds have renowned antimicrobial properties and lack cytotoxicity in eukaryotic cells as well as resistance mechanisms in bacteria. Despite these advantages, their antimicrobial activity has only been tested in vitro, and derivatives improving this activity have not been reported. In this work, a set of 14 OA and MA C-28 amide derivatives have been synthesized. Two of these derivatives, MA-HDA and OA-HDA, increase the in vitro antimicrobial activity of the parent compounds while reducing their toxicity in most of the Gram-positive bacteria tested, including a methicillin-resistant Staphylococcus aureus-MRSA. MA-HDA also shows an enhanced in vivo efficacy in a Galleria mellonella invertebrate animal model of infection. A preliminary attempt to elucidate their mechanism of action revealed that these compounds are able to penetrate and damage the bacterial cell membrane. More significantly, their capacity to reduce antibiofilm formation in catheters has also been demonstrated in two sets of conditions: a static and a more challenged continuous-flow S. aureus biofilm.
- 14 September 2018
- Published by Wiley in Phytochemical Analysis
- Vol. 30 (1) , 89-94
Quantitative NMR analysis of L‐Dopa in seeds from two varieties of Mucuna pruriens
Introduction: L‐Dopa, a key neurotransmitter used to treat neural disorders such as Parkinson's disease, is found in the seeds of the genus Mucuna at a sufficient concentration for possible commercial use.Objective: To develop a simple and reliable method to extract L‐Dopa from M. pruriens seeds in an aqueous medium and then quantitate this compound using a 1H qNMR method (internal standard); and also to evaluate the accuracy and reproducibility of this method with an NMR calibration curve.Methodology: The extraction method of L‐Dopa from M. pruriens was optimized. The quantitation with single point quantitative NMR (qNMR) and NMR calibration curve was based on the resonance properties of the main functional groups of the L‐Dopa molecule, in particular the signals of the three aromatic protons, which were compared with the signal of an internal standard such as syringic acid. The accuracy (precision and trueness) and reproducibility of both NMR techniques were evaluated.Results: The methods of single point qNMR and NMR calibration curve, applied to the seeds of two M. pruriens varieties, gave very similar L‐Dopa contents: 3.0–3.2% and 3.0–3.1%, respectively.Conclusion: The statistical analysis confirmed the accuracy and reproducibility of this single point qNMR method (internal standard) for determining L‐Dopa, as well as other commercial preparations of this species, without performing an NMR calibration curve.
- 14 September 2018
- Published by Wiley in Phytochemical Analysis
- Vol. 30 (1) , 89-94
Quantitative NMR analysis of L‐Dopa in seeds from two varieties of Mucuna pruriens
Introduction: L‐Dopa, a key neurotransmitter used to treat neural disorders such as Parkinson's disease, is found in the seeds of the genus Mucuna at a sufficient concentration for possible commercial use.Objective: To develop a simple and reliable method to extract L‐Dopa from M. pruriens seeds in an aqueous medium and then quantitate this compound using a 1H qNMR method (internal standard); and also to evaluate the accuracy and reproducibility of this method with an NMR calibration curve.Methodology: The extraction method of L‐Dopa from M. pruriens was optimized. The quantitation with single point quantitative NMR (qNMR) and NMR calibration curve was based on the resonance properties of the main functional groups of the L‐Dopa molecule, in particular the signals of the three aromatic protons, which were compared with the signal of an internal standard such as syringic acid. The accuracy (precision and trueness) and reproducibility of both NMR techniques were evaluated.Results: The methods of single point qNMR and NMR calibration curve, applied to the seeds of two M. pruriens varieties, gave very similar L‐Dopa contents: 3.0–3.2% and 3.0–3.1%, respectively.Conclusion: The statistical analysis confirmed the accuracy and reproducibility of this single point qNMR method (internal standard) for determining L‐Dopa, as well as other commercial preparations of this species, without performing an NMR calibration curve.
- 30 August 2018
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 81 (9) , 2075-2082
Semisynthesis of ω-Hydroxyalkylcarbonate Derivatives of Hydroxytyrosol as Antitrypanosome Agents
Several lipophilic ω-hydroxyalkylcarbonate hydroxytyrosol derivatives and also their corresponding dimeric derivatives have been synthesized, coupling the primary hydroxy group of this phenolic compound with several terminal diols of different chain lengths, by the use of a carbonate linker. The trypanocidal activity and cytotoxicity of these ω-hydroxyalkylcarbonate derivatives of hydroxytyrosol and known alkylcarbonate derivatives of hydroxytyrosol were assessed. Three of the hydroxytyrosol alkylcarbonate derivatives were active against Trypanosoma brucei: two with an alkyl chain of average size (0.2 and 0.5 μM) and another with a double bond in the alkyl chain (0.4 μM). These values suggest an increase in activity with respect to hydroxytyrosol (264-, 90-, and 116-fold, respectively). Furthermore, these compounds showed high selectivity indices against MRC-5, a nontumor human cell line (62, 71, and 39, respectively). Some other ω-hydroxyalkylcarbonate and alkylcarbonate derivatives of hydroxytyrosol were also active against T. brucei within a low micromolar range (about 1 μM).
- 30 August 2018
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 81 (9) , 2075-2082
Semisynthesis of ω-Hydroxyalkylcarbonate Derivatives of Hydroxytyrosol as Antitrypanosome Agents
Several lipophilic ω-hydroxyalkylcarbonate hydroxytyrosol derivatives and also their corresponding dimeric derivatives have been synthesized, coupling the primary hydroxy group of this phenolic compound with several terminal diols of different chain lengths, by the use of a carbonate linker. The trypanocidal activity and cytotoxicity of these ω-hydroxyalkylcarbonate derivatives of hydroxytyrosol and known alkylcarbonate derivatives of hydroxytyrosol were assessed. Three of the hydroxytyrosol alkylcarbonate derivatives were active against Trypanosoma brucei: two with an alkyl chain of average size (0.2 and 0.5 μM) and another with a double bond in the alkyl chain (0.4 μM). These values suggest an increase in activity with respect to hydroxytyrosol (264-, 90-, and 116-fold, respectively). Furthermore, these compounds showed high selectivity indices against MRC-5, a nontumor human cell line (62, 71, and 39, respectively). Some other ω-hydroxyalkylcarbonate and alkylcarbonate derivatives of hydroxytyrosol were also active against T. brucei within a low micromolar range (about 1 μM).